▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3889 by analyst upside · 2026-11-14
VTRS
Viatris Inc.
Healthcare · Market Cap $24B · P/E 0x
ANALYST PRICE TARGET
+2.3%
implied upside to consensus target
Current Price $20.82
Consensus Target $21.3
Bull Target $28.0
Bear Target $14.0
Analysts Covering 10
ANALYST CONSENSUS - BUY
Strong Buy
1
Buy
5
Hold
3
Sell
1
52-Week Low $10.15
52-Week High $21.2
YTD Return +71.0%
FUNDAMENTALS
Market Cap $24B
P/E Ratio (TTM) N/A
Forward P/E 7.6x
EPS (TTM) $-0.53
PEG Ratio 3.76
Dividend Yield 2.32%
Revenue (TTM) $14.7B
Profit Margin -4.1%
52-WEEK RANGE
52-Week Low $10.15
52-Week High $21.2
Current Price $20.82
Bear Target $14.0
Bull Target $28.0
● Now $20.82 ● Target $21.3
TRADING DATA
Avg Volume 8.7M
YTD Return +71.0%
Analyst Count 10
Consensus Buy
Upside to Target +2.3%
Last Updated 2026-11-14

ANALYST SUMMARY

Viatris Inc. (VTRS) is currently trading at $20.82 with a Wall Street consensus price target of $21.3, implying potential upside of 2.3% over the next 12 months. 10 analysts currently cover VTRS, with a consensus rating of Buy - 60% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $28.0, while the most cautious has a target of $14.0.

VTRS operates in the Healthcare sector with a market capitalisation of $24B. The stock is up 71.0% year-to-date and is currently trading near the upper end of its 52-week range of $10.15 – $21.2.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for VTRS, with each firm's 90-day track record across all stocks we track. See full firm rankings →

JP Morgan - Reiterated
Neutral → Neutral 2026-11-07 43% win rate (7 calls)
Piper Sandler - Reiterated
Neutral → Neutral 2026-10-26 14% win rate (7 calls)
JP Morgan - Reiterated
Neutral → Neutral 2026-10-21 43% win rate (7 calls)
UBS - Reiterated
Buy → Buy 2026-10-05 33% win rate (6 calls)
Oppenheimer ● Initiated
Outperform 2026-09-23 14% win rate (7 calls)
Piper Sandler - Reiterated
Neutral → Neutral 2026-09-16 14% win rate (7 calls)
Leerink Partners ● Initiated
Outperform 2026-09-09 29% win rate (7 calls)
Argus Research - Reiterated
Buy → Buy 2026-09-08 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
49
out of 100
Coverage depth
18/30
Consensus clarity
17/30
Vote unanimity
12/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →